Search Result

Results for "

PR

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Antibody (1) ADC Linker (2) Akt (3) Aldose Reductase (1) Androgen Receptor (9) Apoptosis (26) Aryl Hydrocarbon Receptor (3) Autophagy (10) Bacterial (12) Bcl-2 Family (7) Beta-secretase (1) Biochemical Assay Reagents (1) Calcium Channel (1) Caspase (7) Cathepsin (2) CCR (1) CDK (1) Deubiquitinase (1) Dihydroceramide Desaturase 1 (DES1) (2) DNA Alkylator/Crosslinker (3) DNA/RNA Synthesis (4) Drug Derivative (2) Drug Metabolite (4) EGFR (2) Elastase (1) Endogenous Metabolite (12) Environmental Pollutants (1) Estrogen Receptor/ERR (2) Ferroptosis (1) FLT3 (1) Fungal (2) FXR (7) G protein-coupled Bile Acid Receptor 1 (9) Glucocorticoid Receptor (9) GSK-3 (2) Histone Methyltransferase (2) HIV (9) HIV Protease (8) IFNAR (4) iGluR (1) Influenza Virus (16) Interleukin Related (1) Isotope-Labeled Compounds (9) JAK (2) JNK (1) LDLR (3) LPL Receptor (50) MDM-2/p53 (7) Mineralocorticoid Receptor (1) Mitochondrial Metabolism (1) MMP (4) NO Synthase (5) Notch (1) P-glycoprotein (7) p38 MAPK (2) PAK (1) PARP (1) PD-1/PD-L1 (1) Peptide-Drug Conjugates (PDCs) (1) PERK (1) Phosphatase (3) Phytohormone (1) Progesterone Receptor (28) PROTAC Linkers (3) PROTACs (2) Proteasome (9) Radionuclide-Drug Conjugates (RDCs) (1) Reactive Oxygen Species (ROS) (4) Reference Standards (10) Reverse Transcriptase (1) SARS-CoV (6) Small Interfering RNA (siRNA) (23) STAT (2) STING (2) Tau Protein (1) TGF-beta/Smad (1) TMV (1) TNF Receptor (1) TROP2 (1) VEGFR (1) Wnt (1)
By Research Areas:	Cancer (73) Cardiovascular Disease (5) Endocrinology (22) Infection (32) Inflammation/Immunology (35) Metabolic Disease (27) Neurological Disease (14)
Click Chemistry:	PROTAC Synthesis (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (6) Mouse Pre-designed siRNA Sets (7) Human Pre-designed siRNA Sets (10) Cholesterol (1) siRNAs (23)

180

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-13814

PR-619 35+ Cited Publications	Deubiquitinase Autophagy Apoptosis	Cancer
PR-619 is a broad-range and reversible DUB inhibitor with EC₅₀s of 3.93, 4.9, 6.86, 7.2, and 8.61 μM for USP4, USP8, USP7, USP2, and USP5, respectively. PR-619 induces ER Stress and ER-Stress related apoptosis .

HY-10455

Carfilzomib 60+ Cited Publications PR-171	Proteasome Autophagy Apoptosis	Cancer
Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC₅₀ of 5 nM in ANBL-6 and RPMI 8226 cells.

HY-10964

Vadimezan Maximum Cited Publications 71 Publications Verification DMXAA; ASA-404	STING IFNAR Influenza Virus	Infection Cancer
Vadimezan (DMXAA), the tumor vascular disrupting agent (tumor-VDA), is a murine agonist of the stimulator of interferon genes (STING) and also a potent inducer of type I IFNs and other cytokines. Vadimezan is unable to activate human STING. Vadimezan has anti-influenza virus *H1N1-PR8* activities.

HY-13207

ONX-0914 20+ Cited Publications PR-957	Proteasome Bacterial HIV	Infection Inflammation/Immunology
ONX-0914 (PR-957) is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 blocks cytokine production and attenuates progression of experimental arthritis. ONX-0914 is a noncompetitive irreversible inhibitor of the mycobacterial proteasome (K_i=5.2 μM). ONX-0914 reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1 .

HY-101395

W146 5 Publications Verification	LPL Receptor Apoptosis	Metabolic Disease Cancer
W146 is a selective antagonist of sphingosine-1-phosphate receptor 1 (S1PR1) with an EC₅₀ value of 398 nM.

HY-12113

Oprozomib 3 Publications Verification ONX 0912; PR-047	Proteasome Autophagy Apoptosis	Cancer
Oprozomib (PR-047) is an orally bioavailable and selective peptide epoxyketone proteasome inhibitor with IC₅₀s of 36 and 82 nM for proteasome (β5) and immunoproteasome (LMP7), respectively. Oprozomib (ONX 0912) induces apoptosis in MM cells .

HY-119384

Promegestone 1 Publications Verification R-5020; Surgestone	Progesterone Receptor	Endocrinology Cancer
Promegestone (R-5020), a progestin, is a potent progesterone receptor (PR) agonist. Promegestone has the potential for endocrine regulation and cancer research .

HY-176533

S1PR5-IN-1	LPL Receptor	Neurological Disease
S1PR5-IN-1 (Compound 7a) is a highly selective *S1PR5* antagonist and orally bioavailable inhibitor with a human *S1PR5* IC₅₀ of 85.4 nM and human *S1PR5* K_a of 2.173 nM.S1PR5-IN-1 binds to *S1PR5* and inhibits natural killer cell migration toward sphingosine-1-phosphate.S1PR5-IN-1 can be used for the research of multiple sclerosis .

HY-P99489

Budigalimab ABBV 181; PR 1648817	PD-1/PD-L1	Inflammation/Immunology Cancer
Budigalimab (ABBV 181; PR 1648817) is a humanized, recombinant IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab has an Fc mutation that reduces the inhibition of Fc receptor interactions and effector factors. Budigalimab can block the binding of PD-1 and PD-L1, which has anti-tumor activity. Budigalimab can be used in the study of solid tumors .

HY-P99899

Samrotamab PR-1498487	ADC Antibody	Cancer
Samrotamab (PR-1498487) is a humanized IgG1-κ chimeric antibody targeting LRRC15. Samrotamab markedly reduces bladder cancer cells viability and inhibits clonogenic growth, migratory and invasive capabilities. Samrotamab significantly increases LRRC15 mRNA level while suppressing SCG5 mRNA expression. Samrotamab can be used for synthesis of ADC ABBV-085 .

HY-17611

Etripamil MSP-2017; (-)-MSP-2017	Calcium Channel	Cardiovascular Disease Neurological Disease
Etripamil (MSP-2017) is a short-acting, L-type calcium-channel antagonist. Etripamil inhibits calcium influx through slow calcium channels, thereby slowing AV node conduction and prolonging the AV node refractory period. Etripamil increases heart rate and decreases systolic blood pressure. Etripamil can be used in the study of paroxysmal supraventricular tachycardia (PSVT) .

HY-13660

Mocravimod hydrochloride 2 Publications Verification KRP-203	LPL Receptor Reactive Oxygen Species (ROS) Akt GSK-3 JAK STAT	Metabolic Disease Inflammation/Immunology Cancer
Mocravimod (hydrochloride) is an orally active sphingosine-1-phosphate receptor (S1PR) modulator that blocks the signal required by T cells to egress from lymph nodes and other lymphoid organs. Mocravimod (hydrochloride) preferentially binds to *S1PR1* over S1PR2 and S1PR3 in cardiomyocytes. Mocravimod (hydrochloride) significantly lowered the concentration of reactive oxygen species (ROS), prevented mitochondrial permeability transition pore opening, boosted mitochondrial membrane potential (MMP), and increased phosphorylation of AKT, EKR, GSK-3β, JAK2, and STAT3. Mocravimod (hydrochloride) retains T cell effector function. Mocravimod (hydrochloride) can be used for the study of acute myelogenous leukemia, diabetes and Myocardial Ischemia-Reperfusion Injury (MIRI) .

HY-109038

Mocravimod 2 Publications Verification KRP-203 free base	LPL Receptor Reactive Oxygen Species (ROS) Mitochondrial Metabolism Akt GSK-3 JAK STAT	Cardiovascular Disease Metabolic Disease Inflammation/Immunology Cancer
Mocravimod (KRP-203 free base) is a sphingosine-1-phosphate receptor (S1PR) modulator that blocks the signal required by T cells to egress from lymph nodes and other lymphoid organs. Mocravimod preferentially binds to *S1PR1* over S1PR2 and S1PR3 in cardiomyocytes. Mocravimod significantly lowered the concentration of reactive oxygen species (ROS), prevented mitochondrial permeability transition pore opening, boosted mitochondrial membrane potential (MMP), and increased phosphorylation of AKT, EKR, GSK-3β, JAK2, and STAT3. Mocravimod retains T cell effector function. Mocravimod can be used for the study of acute myelogenous leukemia, diabetes and Myocardial Ischemia-Reperfusion Injury (MIRI) .

HY-123587

PR-924	Proteasome Apoptosis	Cancer
PR-924 is a selective tripeptide epoxyketone immunoproteasome subunit LMP-7 inhibitor with an IC₅₀ of 22 nM. PR-924 covalently modifies proteasomal N-terminal threonine active sites. PR-924 inhibits growth and triggers apoptosis in multiple myeloma (MM) cells. PR-924 has antitumor activities .

HY-163472

PR280	Dihydroceramide Desaturase 1 (DES1)	Neurological Disease Metabolic Disease Cancer
PR280 is a dihydroceramide desaturase 1 (Des1) inhibitor with an IC₅₀ of 700 nM. PR280 is used for the research of metabolic diseases, cancers, and neurodegenerative diseases .

HY-15606

Tanaproget 1 Publications Verification NSP-989	Progesterone Receptor	Endocrinology
Tanaproget is an orally effective, selective nonsteroidal progesterone receptor (PR) agonist targeting human PR with an IC₅₀ of 1.7 nM. Tanaproget promotes the interaction between PR receptors and coactivators (such as SRC-1), thereby inhibiting the secretion of matrix metalloproteinases (MMP-3/MMP-7) and reducing endometrial tissue invasion and angiogenesis. Tanaproget can be used for contraception and endometriosis inhibition research .

HY-P99852

Dilpacimab ABT165; PR1283233	VEGFR Notch	Cancer
Dilpacimab (ABT165) is a bispecific variable domain immunoglobulin. Dilpacimab binds to and inhibits DLL4 and VEGF and acts as a tumor growth inhibitor. Dilpacimab can be used in research related to metastatic colorectal cancer and advanced solid tumors .

HY-16405

PR-104	DNA Alkylator/Crosslinker	Cancer
PR-104 is a selective hypoxia-activated DNA cross-linking agent and can be used for the research of multiple tumor xenograft models. PR-104, as a nitrogen mustard pre-proagent, is converted efficiently to the more lipophilic dinitrobenzamide mustards alcohol PR-104A .

HY-126145

S1PR1 modulator 1	LPL Receptor	Inflammation/Immunology
S1PR1 modulator 1 is a selective *S1PR1* inhibitor, with a pIC₅₀ of 7.6, with >40- and >80-fold selectivity, over the other S1PR isoforms S1PR2/3/4 .

HY-109963

PR5-LL-CM01	Histone Methyltransferase	Cancer
PR5-LL-CM01 is a potent protein arginine methyltransferase 5 (PRMT5) inhibitor (IC₅₀= 7.5 μM). Anti-tumor activies .

HY-11028

PF-02413873 PF-2413873	Progesterone Receptor	Endocrinology
PF-02413873 (PF-2413873) is a potent selective, fully competitive and orally active nonsteroidal progesterone receptor (PR) antagonist, with a K_i of 2.6 nM. PF-02413873 can block progesterone binding and PR nuclear translocation, and inhibit endometrial growth in vivo .

HY-P10697A

VH4127 TFA	LDLR	Metabolic Disease
VH4127 TFA is a cyclic peptide targeting the low density lipoprotein receptor (LDLR) with a K_D of 18 nM for hLDLR. VH4127 TFA specifically binds to rodent and human epidermal growth factor (EGF) homology domain of LDLR .

HY-136578

RP101988	LPL Receptor Drug Metabolite	Inflammation/Immunology Cancer
RP101988, the major active metabolite of Ozanimod, is a selective, potent *S1PR1* (sphingosine-1-phosphate receptor 1) agonist, with EC₅₀s of 0.19 nM and 32.8 nM for S1PR1 and S1PR5, respectivlely .

HY-P1259A

PR-39 TFA	Proteasome Bacterial	Inflammation/Immunology
PR-39 TFA, a natural proline- and arginine-rich antibacterial peptide, is a noncompetitive, reversible and allosteric proteasome inhibitor. PR-39 TFAreversibly binds to the α7 subunit of the proteasome and blocks degradation of NF-κB inhibitor IκBα by the ubiquitin-proteasome pathway. PR-39 TFA stimulates angiogenesis, inhibits inflammatory responses and significant reduces myocardial infarct size in mice .

HY-14572

PR-104A SN 27858	DNA Alkylator/Crosslinker Drug Metabolite	Cancer
PR-104A (SN 27858) is the alcohol metabolite of phosphate proagent PR-104. PR-104A is a hypoxia-selective DNA cross-linking agent/DNA-damaging agent and cytotoxin. Antitumor Activity . PR-104A is metabolized under hypoxia by the 1-electron NADPH:cytochrome P450 oxidoreductase. PR-104A can be used for the research of relapsed/refractory T-lineage acute lymphoblastic leukemia (T-ALL) .

HY-10455R

Carfilzomib (Standard) PR-171 (Standard)	Reference Standards Proteasome Autophagy Apoptosis	Cancer
Carfilzomib (Standard) is the analytical standard of Carfilzomib. This product is intended for research and analytical applications. Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC₅₀ of 5 nM in ANBL-6 and RPMI 8226 cells.

HY-P1788

Influenza A NP(366-374) Strain A/PR/8/35	Influenza Virus	Infection
Influenza A NP(366-374) Strain A/PR/8/35 is an H2-Db-restricted epitope from Influenza A/PR/8/35 nucleoprotein .

HY-P990827

Anti-TROP-2 Antibody (Pr1E11)	TROP2	Cancer
Anti-TROP-2 Antibody (Pr1E11) is a kind of mouse IgG1 κ chimeric antibody inhibitor, targeting to human TROP-2. Anti-TROP-2 Antibody (Pr1E11) specifically binds to TROP-2 with high affinity and shows low internalization activitv. Anti-TROP-2 Antibody (Pr1E11) can be used for the research of cancer, such as epithelial cancer and primary pancreatic cancer .

HY-13207A

ONX-0914 TFA 20+ Cited Publications PR-957 TFA	Proteasome Bacterial HIV	Infection Inflammation/Immunology
ONX-0914 (PR-957) TFA is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 TFA blocks cytokine production and attenuates progression of experimental arthritis. ONX-0914 TFA is a noncompetitive irreversible inhibitor of the mycobacterial proteasome (K_i=5.2 μM). ONX-0914 TFA reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1 .

HY-P990904

Azirkitug PR-1925514	CCR	Inflammation/Immunology
HY-P990904 is an CCR8-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-136576

RP101075 1 Publications Verification	LPL Receptor Drug Metabolite	Inflammation/Immunology
RP101075, an active metabolite of Ozanimod, is a potent, orally active *S1PR* (sphingosine-1-phosphate receptor 1) agonist, with an EC₅₀ of 0.27 nM. RP101075 displays >100-fold selectivity over S1PR5 (EC₅₀=5.9 nM) and >10000-fold over S1PR 2, 3, and 4. RP101075 displays superior cardiovascular safety profile .

HY-101395A

W146 TFA 5 Publications Verification	LPL Receptor Apoptosis	Metabolic Disease Cancer
W146 TFA is a selective antagonist of sphingosine-1-phosphate receptor 1 (S1PR1) with an EC₅₀ value of 398 nM.

HY-157493

PR antagonist 1	Progesterone Receptor	Endocrinology
PR antagonist 1 (compound 8) is a selective progesterone receptor (PR) antagonist, and can be used for the research of a variety of progesterone-related diseases and disorders such as endometriosis and uterine fibroids .

HY-W873634

TRAP TRAP-PR	Radionuclide-Drug Conjugates (RDCs)	Cancer
TRAP-Pr is a radionuclide conjugate (RDC) that can bind to the radionuclide [68]Ga. RDCs have the ability to specifically target biomolecules and can be used in medical imaging or therapy. TRAP-Pr can be further functionalized with acetone and used in click chemistry CuAAC reactions to conjugate other labeled molecules.

HY-RS12391

S1PR1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA) LPL Receptor	Others
S1PR1 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1PR1 Human Pre-designed siRNA Set A S1PR1 Human Pre-designed siRNA Set A

HY-100953

CYM-5520 1 Publications Verification	LPL Receptor	Metabolic Disease
CYM-5520 is a selective and allosteric sphingosine 1-phosphate receptor 2 (S1PR2) agonist with an EC₅₀ of 480 nM. CYM-5520 does not activate S1PR1, S1PR3, S1PR4 and S1PR5 receptors. CYM-5520 can co-bind in the S1PR2 receptor with S1P. CYM-5520 can be used for osteoporosis research .

HY-10455S

Carfilzomib-d8	Isotope-Labeled Compounds Proteasome Autophagy Apoptosis	Cancer
Carfilzomib-d₈ is deuterium labeled Carfilzomib. Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells.

HY-116170

SN34037	Aldose Reductase	Cancer
SN34037 is a specific inhibitor of Aldo-keto reductase 1C3 (AKR1C3, EC 1.1.1.188) with the ability to inhibit the cytotoxic activity of PR-104A. SN34037-sensitive coumberone reduction provides a rapid and specific assay for AKR1C3 activity. SN34037 inhibits the aerobic cytotoxicity of PR-104A in TF1 erythroleukemia cells with high AKR1C3 expression, but not in Nalm6 pre-B acute lymphoblastic leukemia cells with low AKR1C3 expression .

HY-160604

Remacemide FPL 12924; PR 934-423; FPL 13592	iGluR	Neurological Disease
Remacemide (FPL 12924) is an orally active, non-competitive, low-affinity NMDA receptor antagonist. Remacemide shows neuroprotection activity in animal models of hypoxia and ischemic stroke. Remacemide is also an anticonvulsant, and can be used in Parkinson's disease and Huntington's disease research .

HY-P1259

PR-39	Proteasome Bacterial	Inflammation/Immunology
PR-39, a natural proline- and arginine-rich antibacterial peptide, is a noncompetitive, reversible and allosteric proteasome inhibitor. PR-39 reversibly binds to the α7 subunit of the proteasome and blocks degradation of NF-κB inhibitor IκBα by the ubiquitin-proteasome pathway. PR-39 stimulates angiogenesis, inhibits inflammatory responses and significant reduces myocardial infarct size in mice .

HY-126484

Eremofortin B	Fungal	Others
Eremofortin B is a sesquiterpenoid compound synthesized by penicillium roqueforti PR Toxin (PRT) .

HY-RS12394

S1PR2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA) LPL Receptor	Others
S1PR2 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1PR2 Human Pre-designed siRNA Set A S1PR2 Human Pre-designed siRNA Set A

HY-12073

WAY-255348	Progesterone Receptor	Endocrinology Cancer
W-255348 is an effective non-steroidal progesterone receptor (PR) antagonist that acquires antagonist activity by binding to and subsequently blocking progesterone induced nuclear accumulation, phosphorylation, and PR promoter interactions. WAY-255348 can be used in the research of reproductive disorders or PR-positive breast cancer .

HY-P99892

Serclutamab PR-1594407; DC-1630423	EGFR	Others
Serclutamab is a humanized chimeric antibody targeting EGFR IgG1-κ. Mainly expressed by CHO (Chinese Hamster Ovary) cells .

HY-106827

Trimegestone RU 27987	Progesterone Receptor Androgen Receptor Phosphatase	Endocrinology
Trimegestone (RU 27987) is an orally active 19-norpregnane progestin. Trimegestone binds to progesterone receptor (PR) with an IC₅₀ value of 3.3 nM (rat PR). Trimegestone increases alkaline phosphatase activity (EC₅₀=0.1 nM) but not luciferase activity. Trimegestone also shows a weak antiandrogenic activity (weak androgen receptor affinity). Trimegestone can be used in studies of contraception or menopausal syndromes .

HY-178491

S1PR1 agonist 3	LPL Receptor	Inflammation/Immunology
S1PR1 agonist 3 (Compound Y18) is a highly selective S1PR1 receptor agonist (EC₅₀=0.98 nM). S1PR1 agonist 3 is promising for research of autoimmune diseases such as multiple sclerosis and ulcerative colitis .

HY-143865

S1PR1 agonist 2	LPL Receptor	Inflammation/Immunology
S1PR1 agonist 2 is a potent agonist of *S1PR1*. Sphingosine-1-phosphate (S1P) is a cell membrane-derived lysophospholipid signalling molecule that exerts its physiological functions mainly by stimulating some members of the G protein-coupled receptor family. S1PR1 agonist 2 has the potential for the research of autoimmune diseases (extracted from patent WO2021175225A1, compound 1) .

HY-W673679

(1R,2S)-Deoxy-PR280	Dihydroceramide Desaturase 1 (DES1)	Others
(1R,2S)-Deoxy-PR280 is a competitive inhibitor of dihydroceramide desaturase, with a K_i of 6 µM .

HY-P10697

VH4127	LDLR	Metabolic Disease
VH4127 is a cyclic peptide targeting the low density lipoprotein receptor (LDLR) with a K_D of 18 nM for hLDLR. VH4127, bearing non-natural amino acid residues, specifically binds to rodent and human epidermal growth factor (EGF) homology domain of LDLR .

HY-P10698

VH-N412	Peptide-Drug Conjugates (PDCs) LDLR	Neurological Disease
VH-N412 is a vectorized neuropeptide (NT) with good blood-brain barrier permeability. VH-N412 binds to the low-density lipoprotein receptor (LDLR) and neuropeptide receptor 1 (NTSR-1), and acts as a pharmacological-induced hypothermia (PIH) inducer. VH-N412 exhibits anticonvulsant and neuroprotective effects, and can be used in the study of neurological diseases such as epilepsy.

Cat. No.	Product Name	Target	Research Area

HY-P10697A

VH4127 TFA	LDLR	Metabolic Disease
VH4127 TFA is a cyclic peptide targeting the low density lipoprotein receptor (LDLR) with a K_D of 18 nM for hLDLR. VH4127 TFA specifically binds to rodent and human epidermal growth factor (EGF) homology domain of LDLR .

HY-P1259A

PR-39 TFA	Proteasome Bacterial	Inflammation/Immunology
PR-39 TFA, a natural proline- and arginine-rich antibacterial peptide, is a noncompetitive, reversible and allosteric proteasome inhibitor. PR-39 TFAreversibly binds to the α7 subunit of the proteasome and blocks degradation of NF-κB inhibitor IκBα by the ubiquitin-proteasome pathway. PR-39 TFA stimulates angiogenesis, inhibits inflammatory responses and significant reduces myocardial infarct size in mice .

HY-P1788

Influenza A NP(366-374) Strain A/PR/8/35	Influenza Virus	Infection
Influenza A NP(366-374) Strain A/PR/8/35 is an H2-Db-restricted epitope from Influenza A/PR/8/35 nucleoprotein .

HY-P10461

Abz-Val-Ala-Asp-Nva-Arg-Asp-Arg-Gln-EDDnp	Peptides	Others
Abz-Val-Ala-Asp-Nva-Arg-Asp-Arg-Gln-EDDnp is a fluorescence-quenched peptide substrate for human proteinase 3 (k_cat/K_m = 1,570 mM ^-1s ^-1), and can be used for detection of proteinase 3 (PR3) activity .

HY-P1259

PR-39	Proteasome Bacterial	Inflammation/Immunology
PR-39, a natural proline- and arginine-rich antibacterial peptide, is a noncompetitive, reversible and allosteric proteasome inhibitor. PR-39 reversibly binds to the α7 subunit of the proteasome and blocks degradation of NF-κB inhibitor IκBα by the ubiquitin-proteasome pathway. PR-39 stimulates angiogenesis, inhibits inflammatory responses and significant reduces myocardial infarct size in mice .

HY-P10697

VH4127	LDLR	Metabolic Disease
VH4127 is a cyclic peptide targeting the low density lipoprotein receptor (LDLR) with a K_D of 18 nM for hLDLR. VH4127, bearing non-natural amino acid residues, specifically binds to rodent and human epidermal growth factor (EGF) homology domain of LDLR .

HY-P10698

VH-N412	Peptide-Drug Conjugates (PDCs) LDLR	Neurological Disease
VH-N412 is a vectorized neuropeptide (NT) with good blood-brain barrier permeability. VH-N412 binds to the low-density lipoprotein receptor (LDLR) and neuropeptide receptor 1 (NTSR-1), and acts as a pharmacological-induced hypothermia (PIH) inducer. VH-N412 exhibits anticonvulsant and neuroprotective effects, and can be used in the study of neurological diseases such as epilepsy.

HY-P1436

Acetyl-pepstatin	HIV	Infection
Acetyl-pepstatin is a potent classical inhibitor of aspartic proteases (PRs) with XMRV PR and HIV-1 PR K_i values of 712 nM and 13 nM .

HY-P10400A

AtPep1 TFA	Phytohormone	Infection
AtPep1 TFA is an endogenous inducer of innate immune responses. AtPep1 TFA can be isolated from Arabidopsis thaliana leaves. AtPep1 TFA activates the transcription of defensin (PDF1.2), the expression of PROPEP1, the synthesis of hydrogen peroxide (H₂O₂) near leaf veins, and the alkalization of Arabidopsis suspension cell culture medium. AtPep1 TFA induces the expression of genes encoding defensins and *PR-1. AtPep1 TFA is applicable to studies related to Pythium irregulare* infection and pathogen infection .

HY-P5550

Urumin	Influenza Virus	Infection
Urumin has antiviral activity against the human influenza A virus. Urumin inhibits the growth of PR8 influenza virus (IC₅₀: 3.8 μM). Urumin targets the conserved stalk of H1 hemagglutini, and is effective at neutralizing drug-resistant H1 influenza viruses. Urumin protects naive mice from lethal influenza infection .

HY-P5415

DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS	HIV	Others
DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS is a biological active peptide. (DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS is also called HIV protease substrate I in some literature. It is widely used for the continuous assay for HIV protease activity. The 11-K_d protease (PR) encoded by the human immunodeficiency virus 1 (HIV-1) is essential for the correct processing of viral polyproteins and the maturation of infectious virus, and is therefore a target for the design of selective acquired immunodeficiency syndrome (AIDS) therapeutics. The FRET-based fluorogenic substrate is derived from a natural processing site for HIV-1 PR. Incubation of recombinant HIV-1 PR with the fluorogenic substrate resulted in specific cleavage at the Tyr-Pro bond and a time-dependent increase in fluorescence intensity that is linearly related to the extent of substrate hydrolysis. The fluorescence quantum yields of the HIV-1 PR substrate in the FRET assay increased by 40.0- and 34.4-fold, respectively, per mole of substrate cleaved. Because of its simplicity and precision in the determination of reaction rates required for kinetic analysis, this substrate offers many advantages over the commonly used HPLC or electrophoresis-based assays for peptide substrate hydrolysis by retroviral PRs. Abs/Em = 340nm/490nm.)

Cat. No.	Product Name	Target	Research Area	Image

HY-P99489

Budigalimab ABBV 181; PR 1648817	PD-1/PD-L1	Inflammation/Immunology Cancer
Budigalimab (ABBV 181; PR 1648817) is a humanized, recombinant IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab has an Fc mutation that reduces the inhibition of Fc receptor interactions and effector factors. Budigalimab can block the binding of PD-1 and PD-L1, which has anti-tumor activity. Budigalimab can be used in the study of solid tumors .

HY-P99899

Samrotamab PR-1498487	ADC Antibody	Cancer
Samrotamab (PR-1498487) is a humanized IgG1-κ chimeric antibody targeting LRRC15. Samrotamab markedly reduces bladder cancer cells viability and inhibits clonogenic growth, migratory and invasive capabilities. Samrotamab significantly increases LRRC15 mRNA level while suppressing SCG5 mRNA expression. Samrotamab can be used for synthesis of ADC ABBV-085 .

HY-P99852

Dilpacimab ABT165; PR1283233	VEGFR Notch	Cancer
Dilpacimab (ABT165) is a bispecific variable domain immunoglobulin. Dilpacimab binds to and inhibits DLL4 and VEGF and acts as a tumor growth inhibitor. Dilpacimab can be used in research related to metastatic colorectal cancer and advanced solid tumors .

HY-P990827

Anti-TROP-2 Antibody (Pr1E11)	TROP2	Cancer
Anti-TROP-2 Antibody (Pr1E11) is a kind of mouse IgG1 κ chimeric antibody inhibitor, targeting to human TROP-2. Anti-TROP-2 Antibody (Pr1E11) specifically binds to TROP-2 with high affinity and shows low internalization activitv. Anti-TROP-2 Antibody (Pr1E11) can be used for the research of cancer, such as epithelial cancer and primary pancreatic cancer .

HY-P990904

Azirkitug PR-1925514	CCR	Inflammation/Immunology
HY-P990904 is an CCR8-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P99892

Serclutamab PR-1594407; DC-1630423	EGFR	Others
Serclutamab is a humanized chimeric antibody targeting EGFR IgG1-κ. Mainly expressed by CHO (Chinese Hamster Ovary) cells .

HY-P992444

PR200	TNF Receptor	Cancer
PR200 is an anti-Human TNFSF15/TL1A antibody.

HY-P992034

APG808 PR001	Interleukin Related	Inflammation/Immunology
APG808 is an anti-human IL-4Rα monoclonal antibody. APG808 binds to IL-4Rα, prevents IL-13Rα1/IL-4Rα heterodimer formation, and disrupts IL-13 and IL-4 mediated signaling. APG808 ablates Fc and complement effector functions. APG808 can be used for the research of chronic obstructive pulmonary disease, asthma, atopic dermatitis .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N1423

Glycocholic acid 3 Publications Verification	Structural Classification Human Gut Microbiota Metabolites Classification of Application Fields Endogenous metabolite Disease Research Fields Steroids Source Classification Cancer	P-glycoprotein Bcl-2 Family G protein-coupled Bile Acid Receptor 1 Endogenous Metabolite Bacterial Apoptosis FXR Caspase MDM-2/p53 LPL Receptor
Glycocholic acid is a bile acid derivative. Glycocholic acid downregulates MDR1, Bcl-2, MRP1, MRP2 and FXR, upregulates Bax, p53, caspase-9, caspase-3, TGR5 and *S1PR2. Glycocholic acid inhibits multidrug resistance and efflux pumps, induces mitochondrial apoptosis*, and enhances chemosensitivity. Glycocholic acid modulates related bile acid receptor signaling. Glycocholic acid suppresses growth and conjugation of Enterobacteriaceae and increases their antibiotic susceptibility. Glycocholic acid can be used for the research of colon adenocarcinoma and cholangiocarcinoma (CCA) .

HY-N7922

Urolithin M5 1 Publications Verification Decarboxyellagic acid	Structural Classification Canarium album (Lour.) Rauesch. Phenols Polyphenols Plants Burseraceae Source Classification	Influenza Virus p38 MAPK EGFR Akt Reactive Oxygen Species (ROS) Apoptosis
Urolithin M5 (Decarboxyellagic acid) is an orally active influenza virus neuraminidase inhibitor and neuroprotective agent, with IC₅₀ values of 174.8 μM (HK68), 191.5 μM (pdm09), 243.2 μM (WSN) and 257.1 μM (PR8) against four influenza virus neuraminidases, respectively. Urolithin M5 inhibits viral neuraminidase activity, thereby blocking influenza virus replication (including oseltamivir (HY-13317)-resistant strains), protecting infected mammals from death and improving pulmonary edema. Urolithin M5 forms a hydrogen-bond stabilized complex with IGF1R, and binds to MAPK14, AKT1, NFKB1 and EGFR. Urolithin M5 reduces reactive oxygen species production, inhibits neuronal apoptosis, restores mitochondrial transmembrane potential, and promotes neurite outgrowth of damaged neuronal cells. Urolithin M5 can be used in research related to influenza virus infection and Alzheimer's disease .

HY-N1423A

Glycocholic acid sodium 3 Publications Verification	Triterpenes Structural Classification Terpenoids Endogenous metabolite Source Classification	P-glycoprotein Bcl-2 Family G protein-coupled Bile Acid Receptor 1 Bacterial Apoptosis FXR Caspase MDM-2/p53 LPL Receptor Endogenous Metabolite
Glycocholic acid sodium is a bile acid derivative. Glycocholic acid downregulates MDR1, Bcl-2, MRP1, MRP2 and FXR, upregulates Bax, p53, caspase-9, caspase-3, TGR5 and *S1PR2. Glycocholic acid sodium inhibits multidrug resistance and efflux pumps, induces mitochondrial apoptosis*, and enhances chemosensitivity. Glycocholic acid sodium modulates related bile acid receptor signaling. Glycocholic acid sodium suppresses growth and conjugation of Enterobacteriaceae and increases their antibiotic susceptibility. Glycocholic acid sodium can be used for the research of colon adenocarcinoma and cholangiocarcinoma (CCA) .

HY-B1899A

Taurodeoxycholic acid sodium hydrate 3 Publications Verification Taurodeoxycholate sodium hydrate	Structural Classification Classification of Application Fields Metabolic Disease Endogenous metabolite Disease Research Fields Steroids Source Classification	G protein-coupled Bile Acid Receptor 1 Endogenous Metabolite
Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate), a bile acid, is an amphiphilic surfactant molecule synthesized from cholesterol in the liver. Taurodeoxycholic acid sodium hydrate activates the *S1PR2* pathway in addition to the TGR5 pathway .

HY-107823

Cholesteryl acetate Cholesterol 3-acetate; Cholesterin acetate; Cholesterol 3β-acetate	Structural Classification Classification of Application Fields Other Diseases Endogenous metabolite Disease Research Fields Steroids Source Classification	Endogenous Metabolite
Cholesteryl acetate (Cholesterol 3-acetate) is a cholesterol ester that is exported from Saccharomyces cerevisiae via a Pry1-dependent mechanism. Cholesteryl acetate binds to the CAP superfamily protein Pry1 via interactions dependent on Pry1’s caveolin-binding motif .

HY-N1423B

Glycocholic acid hydrate 3 Publications Verification	Structural Classification Classification of Application Fields Metabolic Disease Endogenous metabolite Disease Research Fields Steroids Source Classification	Endogenous Metabolite Caspase G protein-coupled Bile Acid Receptor 1 LPL Receptor MDM-2/p53 Bcl-2 Family P-glycoprotein FXR Bacterial Apoptosis
Glycocholic acid hydrate is a bile acid derivative. Glycocholic acid hydrate downregulates MDR1, Bcl-2, MRP1, MRP2 and FXR, upregulates Bax, p53, caspase-9, caspase-3, TGR5 and *S1PR2. Glycocholic acid hydrate inhibits multidrug resistance and efflux pumps, induces mitochondrial apoptosis*, and enhances chemosensitivity. Glycocholic acid hydrate modulates related bile acid receptor signaling. Glycocholic acid hydrate suppresses growth and conjugation of Enterobacteriaceae and increases their antibiotic susceptibility. Glycocholic acid hydrate can be used for the research of colon adenocarcinoma and cholangiocarcinoma (CCA) .

HY-126484

Eremofortin B	Structural Classification Microorganisms Terpenoids Sesquiterpenes Source Classification	Fungal
Eremofortin B is a sesquiterpenoid compound synthesized by penicillium roqueforti PR Toxin (PRT) .

HY-N10843

4-O-Methylepisappanol	Flavanonols Flavonoids Caesalpiniaceae Plants Source Classification	Influenza Virus
4-O-Methylepisappanol (compound 9) is nature product that could be isolated from heartwood of Caesalpinia sappan. 4-O-Methylepisappanol is a potent neuraminidase inhibitor on the surface of influenza viruses with IC₅₀ values of 42.8, 63.2, and 63.2 µM for A/Chicken/Korea/MS96/96 [H9N2], A/PR/8/34 [H1N1], and A/Hong Kong/8/68 [H3N2], respectively .

HY-N15389

Noformicin	Microorganisms Antibiotics Other Antibiotics Source Classification	Influenza Virus
Noformicin has inhibitory effect on mumps virus and Newcastle disease virus in chicken embryo. Noformicin also extended the survival of mice infected with swine, influenza A (PR8) and influenza B (Lee) viruses .

HY-114551

Streptothricin E Racemomycin C; Antibiotic S15-1B	Microorganisms Antibiotics Other Antibiotics Source Classification	Bacterial Fungal
Racemomycin C has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture .

HY-N1836

3-Acetonyl-3-hydroxyoxindole 3-Hydroxy-3-acetonyloxindole	Infection Alkaloids Acanthaceae Classification of Application Fields Plants Disease Research Fields Indole Alkaloids Jacobaea cannabifolia (Less.) E. Wiebe Source Classification	TMV
3-Acetonyl-3-hydroxyoxindole (AHO) is a potent systemic acquired resistance (SAR) inducer in plants. 3-Acetonyl-3-hydroxyoxindole induces resistance in tobacco plants against infection with tobacco mosaic virus (TMV) and the fungal pathogen Erysiphe cichoracearum. 3-Acetonyl-3-hydroxyoxindole increases the level of pathogenesis-related gene 1 (PR-1) expression, salicylic acid (SA) accumulation and phenylalanine ammonia-lyase activity .

HY-W089835R

Sodium taurodeoxycholate hydrate (Standard)	Structural Classification Endogenous metabolite Steroids Source Classification	Reference Standards G protein-coupled Bile Acid Receptor 1 Endogenous Metabolite
Sodium taurodeoxycholate hydrate (Standard) is the analytical standard of Sodium taurodeoxycholate hydrate. This product is intended for research and analytical applications. Sodium taurodeoxycholate hydrate, a bile acid, is an amphiphilic surfactant molecule synthesized from cholesterol in the liver. Sodium taurodeoxycholate hydrate activates the S1PR2 pathway in addition to the TGR5 pathway .

HY-N15618

Antiviral agent 68	Alpinia hainanensis K. Schum. Natural Products Plants Source Classification Zingiberaceae	Influenza Virus
Antiviral agent 68 (Compound 3) is a diarylheptanoid that can be isolated from Alpinia katsumadai. Antiviral agent 68 has weak inhibitory activity against the neuraminidase of influenza virus A/PR/8/34, with an IC₅₀ of 29.75 μM .

HY-N9019

1,4-Epidioxybisabola-2,10-dien-9-one	Terpenoids Sesquiterpenes Plants Curcuma longa Source Classification Zingiberaceae	Influenza Virus
1,4-Epidioxybisabola-2,10-dien-9-one is a 1,4-epidioxy-bisabola-2,12-diene derivate, which can be isolated from Curcuma longa L. 1,4-Epidioxybisabola-2,10-dien-9-one exhibits antiviral activity against influenza virus A/PR/8/34 (H1N1) in the MDCK cell line with an IC₅₀ of 16.79 ± 4.03 μg/mL .

HY-N1423AR

Glycocholic acid sodium (Standard)	Structural Classification Endogenous metabolite Steroids Source Classification	Reference Standards P-glycoprotein Bcl-2 Family G protein-coupled Bile Acid Receptor 1 Bacterial Apoptosis FXR Caspase MDM-2/p53 LPL Receptor Endogenous Metabolite
Glycocholic acid (sodium) (Standard) is the analytical standard of Glycocholic acid sodium (HY-N1423A). This product is intended for research and analytical applications. Glycocholic acid sodium is a bile acid derivative. Glycocholic acid downregulates MDR1, Bcl-2, MRP1, MRP2 and FXR, upregulates Bax, p53, caspase-9, caspase-3, TGR5 and *S1PR2. Glycocholic acid sodium inhibits multidrug resistance and efflux pumps, induces mitochondrial apoptosis*, and enhances chemosensitivity. Glycocholic acid sodium modulates related bile acid receptor signaling. Glycocholic acid sodium suppresses growth and conjugation of Enterobacteriaceae and increases their antibiotic susceptibility. Glycocholic acid sodium can be used for the research of colon adenocarcinoma and cholangiocarcinoma (CCA).

Species:	Virus (6) Human (17) Mouse (1)
Tag:	His (20) Strep (1) Tag Free (2) Avi (4) GST (1) Fc (1)
Source:	HEK293 (9) E. coli Cell-free (1) E. coli (14)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P74613

	PR-Set7 Protein, Human N-lysine methyltransferase KMT5A; PR-Set7; KMT5A; PRSET7; SET8; SETD8	Human	E. coli
	The PR-Set7 Protein methylates Lys-20 of histone H4, repressing gene transcription and aiding cell proliferation and chromatin condensation. It is expressed in multiple tissues, including the prostate (RPKM 17.6), esophagus (RPKM 16.8), and others. PR-Set7 Protein, Human is the recombinant human-derived PR-Set7 protein, expressed by E. coli , with tag free.

HY-P70509

	PRTN3 Protein, Human (HEK293, His, solution) 1 Publications Verification Myeloblastin; AGP7; C-ANCA Antigen; Leukocyte PRoteinase 3; PR-3; PR3; Neutrophil PRoteinase 4; NP-4; P29; Wegener Autoantigen; PRTN3; MBN	Human	HEK293
	PRTN3 is a serine protease that broadly targets elastin, fibronectin, laminin, vitronectin, and collagen types I, III, and IV in vitro, playing a crucial role in extracellular matrix degradation. It modulates endothelial cell barrier function by cleaving and activating the receptor F2RL1/PAR-2 and enhances vascular integrity during neutrophil transendothelial migration. PRTN3 Protein, Human (HEK293, His, solution) is the recombinant human-derived PRTN3 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P70509A

	PRTN3 Protein, Human (HEK293, C-His) Myeloblastin; AGP7; C-ANCA Antigen; Leukocyte PRoteinase 3; PR-3; PR3; Neutrophil PRoteinase 4; NP-4; P29; Wegener Autoantigen; PRTN3; MBN	Human	HEK293
	PRTN3 is a serine protease that broadly targets elastin, fibronectin, laminin, vitronectin, and collagen types I, III, and IV in vitro, playing a crucial role in extracellular matrix degradation.It modulates endothelial cell barrier function by cleaving and activating the receptor F2RL1/PAR-2 and enhances vascular integrity during neutrophil transendothelial migration.PRTN3 Protein, Human (HEK293, C-His) is the recombinant human-derived PRTN3 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P703178

	PPP2R5A Protein, Human (His, Strep) Serine/threonine-PRotein phosphatase 2A 56 kDa regulatory subunit alpha isoform; PP2A B subunit isoform B'-alpha; PP2A B subunit isoform B56-alpha; PP2A B subunit isoform PR61-alpha; PR61alpha; PP2A B subunit isoform R5-alpha; PPP2R5A; Homo sapiens; Human; PR61alpha;	Human	E. coli
	PPP2R5A Protein, Human (His, Strep) is the recombinant human-derived PPP2R5A, expressed by E. coli , with Strep, His labeled tag. ,

HY-P73924

	p24 Protein, HIV-1 (AAB50258, His) CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)	Virus	E. coli
	The capsid protein p24 forms the conical core of the genome RNA-nucleocapsid complex in the virion. Promote immune invasion by hiding the viral DNA detected by CGAS. The viral capsid protein p24 is considered to be another early virological biomarker of infection. p24 Protein, HIV-1 (AAB50258, His) is the recombinant Virus-derived p24 protein, expressed by E. coli , with C-His labeled tag.

HY-P73925

	p24 Protein, HIV-1 (AAA44868, His) CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)	Virus	E. coli
	The capsid protein p24 forms the conical core of the genome RNA-nucleocapsid complex in the virion. Promote immune invasion by hiding the viral DNA detected by CGAS. The viral capsid protein p24 is considered to be another early virological biomarker of infection. p24 Protein, HIV-1 (AAA44868, His) is the recombinant Virus-derived p24 protein, expressed by E. coli , with C-His labeled tag.

HY-P73921

	p24 Protein, HIV-1 (BAH97658, His) CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)	Virus	E. coli
	The capsid protein p24 forms the conical core of the genome RNA-nucleocapsid complex in the virion. Promote immune invasion by hiding the viral DNA detected by CGAS. The viral capsid protein p24 is considered to be another early virological biomarker of infection. p24 Protein, HIV-1 (BAH97658, His) is the recombinant Virus-derived p24 protein, expressed by E. coli , with C-His labeled tag.

HY-P73922

	p24 Protein, HIV-1 (ACI05538, His) CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)	Virus	E. coli
	The capsid protein p24 forms the conical core of the genome RNA-nucleocapsid complex in the virion. Promote immune invasion by hiding the viral DNA detected by CGAS. The viral capsid protein p24 is considered to be another early virological biomarker of infection. p24 Protein, HIV-1 (ACI05538, His) is the recombinant Virus-derived p24 protein, expressed by E. coli , with C-His labeled tag.

HY-P73923

	p24 Protein, HIV-1 (AAB61122, His) CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)	Virus	E. coli
	The capsid protein p24 forms the conical core of the genome RNA-nucleocapsid complex in the virion. Promote immune invasion by hiding the viral DNA detected by CGAS. The viral capsid protein p24 is considered to be another early virological biomarker of infection. p24 Protein, HIV-1 (AAB61122, His) is the recombinant Virus-derived p24 protein, expressed by E. coli , with C-His labeled tag.

HY-P76579

	RIZ1 Protein, Human PR domain zinc finger PRotein 2; MTB-ZF; Zinc finger PRotein RIZ; PRDM2; KMT8; RIZ	Human	E. coli
	RIZ1 Protein, an S-adenosyl-L-methionine-dependent histone methyltransferase, specifically methylates 'Lys-9' of histone H3. Additionally, it acts as a DNA-binding transcription factor, showing affinity for the MTE within the HMOX1 gene. Implicated as a potential activator, RIZ1 suggests a regulatory role in HMOX1 gene expression beyond histone modification. RIZ1 Protein, Human is the recombinant human-derived RIZ1 protein, expressed by E. coli , with tag free.

HY-P704833

	p24 Protein, HIV-1 (AAB50258, HEK293, His) CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)	Virus	HEK293
	p24 Protein, HIV-1 (AAB50258, HEK293, His) is the recombinant virus-derived p24 protein, expressed by HEK293, with C-His tag.

HY-P701105

	RIZ1 Protein, Human (His) PR domain zinc finger PRotein 2; MTB-ZF; Zinc finger PRotein RIZ; PRDM2; KMT8; RIZ	Human	E. coli
	RIZ1 Protein, an S-adenosyl-L-methionine-dependent histone methyltransferase, specifically methylates 'Lys-9' of histone H3. Additionally, it acts as a DNA-binding transcription factor, showing affinity for the MTE within the HMOX1 gene. Implicated as a potential activator, RIZ1 suggests a regulatory role in HMOX1 gene expression beyond histone modification. RIZ1 Protein, Human (His) is the recombinant human-derived RIZ1 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P76580

	RIZ1 Protein, Human (GST) PR domain zinc finger PRotein 2; MTB-ZF; Zinc finger PRotein RIZ; PRDM2; KMT8; RIZ	Human	E. coli
	RIZ1 Protein, an S-adenosyl-L-methionine-dependent histone methyltransferase, specifically methylates 'Lys-9' of histone H3. Additionally, it acts as a DNA-binding transcription factor, showing affinity for the MTE within the HMOX1 gene. Implicated as a potential activator, RIZ1 suggests a regulatory role in HMOX1 gene expression beyond histone modification. RIZ1 Protein, Human (GST) is the recombinant human-derived RIZ1 protein, expressed by E. coli , with N-GST labeled tag.

HY-P76552

	PRTN3 Protein, Human (S203A, HEK293, His) Myeloblastin; AGP7; Leukocyte PRoteinase 3; PR-3; P29; Wegener autoantigen; MBN	Human	HEK293
	PRTN3 is a serine protease that broadly targets elastin, fibronectin, laminin, vitronectin, and collagen types I, III, and IV in vitro, playing a crucial role in extracellular matrix degradation. It modulates endothelial cell barrier function by cleaving and activating the receptor F2RL1/PAR-2 and enhances vascular integrity during neutrophil transendothelial migration. PRTN3 Protein, Human (S203A, HEK293, His) is the recombinant human-derived PRTN3 protein, expressed by HEK293 , with C-His labeled tag and S203A mutation.

HY-P700870

	IGF2R Protein, Human (HEK293, His-Avi) CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI	Human	HEK293
	IGF2R proteins coordinate cellular processes by transporting phosphorylated lysosomal enzymes from the Golgi complex to lysosomes. Lysosomal enzymes with phosphomannosyl residues bind to mannose-6-phosphate receptors in the Golgi apparatus, form complexes, and transport to the acidic prelysosomal compartment. IGF2R Protein, Human (HEK293, His-Avi) is the recombinant human-derived IGF2R protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P700869

	IGF2R Protein, Human (Biotinylated, HEK293, His-Avi) CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI	Human	HEK293
	IGF2R proteins coordinate cellular processes by transporting phosphorylated lysosomal enzymes from the Golgi complex to lysosomes. Lysosomal enzymes with phosphomannosyl residues bind to mannose-6-phosphate receptors in the Golgi apparatus, form complexes, and transport to the acidic prelysosomal compartment. IGF2R Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived IGF2R protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P700871

	IGF2R Protein, Human (Domain 1-3, HEK293, His-Avi) CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI	Human	HEK293
	IGF2R proteins coordinate cellular processes by transporting phosphorylated lysosomal enzymes from the Golgi complex to lysosomes. Lysosomal enzymes with phosphomannosyl residues bind to mannose-6-phosphate receptors in the Golgi apparatus, form complexes, and transport to the acidic prelysosomal compartment. IGF2R Protein, Human (Domain 1-3, HEK293, His-Avi) is the recombinant human-derived IGF2R protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P701061

	IGF2R Protein, Human (Domain 1-7, HEK293, His-Avi) CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI	Human	HEK293
	IGF2R proteins coordinate cellular processes by transporting phosphorylated lysosomal enzymes from the Golgi complex to lysosomes. Lysosomal enzymes with phosphomannosyl residues bind to mannose-6-phosphate receptors in the Golgi apparatus, form complexes, and transport to the acidic prelysosomal compartment. IGF2R Protein, Human (Domain 1-7, HEK293, His-Avi) is the recombinant human-derived IGF2R protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P703904

	IGF2R Protein, Human (HEK293, hFc) insulin like growth factor 2 receptor; CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI	Human	HEK293
	IGF2R proteins coordinate cellular processes by transporting phosphorylated lysosomal enzymes from the Golgi complex to lysosomes. Lysosomal enzymes with phosphomannosyl residues bind to mannose-6-phosphate receptors in the Golgi apparatus, form complexes, and transport to the acidic prelysosomal compartment. IGF2R Protein, Human (HEK293, hFc) is the recombinant human-derived IGF2R protein, expressed by HEK293, with C-hFc labeled tag.

HY-P71121

	Stathmin Protein, Human (C-His) Stathmin; Leukemia-Associated PhosphoPRotein p18; Metablastin; OncoPRotein 18; Op18; PhosphoPRotein p19; pp19; PRosolin; PRotein PR22; pp17; STMN1; C1orf215; LAP18; OP18	Human	E. coli
	Stathmin proteins critically regulate the microtubule filament system by actively destabilizing microtubules, inhibiting assembly, and promoting disassembly. Phosphorylation of Ser-16 is critical for axon formation during neurogenesis, highlighting its importance in neuronal development. Stathmin Protein, Human (C-His) is the recombinant human-derived Stathmin protein, expressed by E. coli , with C-6*His labeled tag.

HY-P71121A

	Stathmin Protein, Human (His) "Stathmin; Leukemia-Associated PhosphoPRotein p18; Metablastin; OncoPRotein 18; Op18; PhosphoPRotein p19; pp19; PRosolin; PRotein PR22; pp17; STMN1; C1orf215; LAP18; OP18 "	Human	E. coli
	Stathmin Protein, a widely distributed cytosolic phosphoprotein, integrates regulatory signals and destabilizes microtubules, crucial for their assembly and disassembly. It exhibits broad expression in various tissues, highlighting its versatile role in cellular processes. Stathmin Protein, Human (His) is the recombinant human-derived Stathmin protein, expressed by E. coli , with N-6*His labeled tag.

HY-P705913

	PPP2R2A Protein, Human (His) PP2A subunit B isoform B55-alpha; PP2A subunit B isoform PR55-alpha; PP2A subunit B isoform R2-alpha; PP2A subunit B isoform alpha	Human	E. coli

HY-P705541

	S1pr2 Protein, Mouse (Cell-Free, His) Sphingosine 1-phosphate receptor 2; S1P receptor 2; S1P2; Endothelial differentiation G-PRotein coupled receptor 5; Lysophospholipid receptor B2; Sphingosine 1-phosphate receptor Edg-5 (S1P receptor Edg-5); Edg5; Gpcr13; Lpb2	Mouse	E. coli Cell-free

HY-P705526

	GADD34/PPP1R15A Protein, Human (His) Apoptosis associated PRotein; GADD 34; Growth arrest and DNA damage inducible 34; Growth arrest and DNA damage-inducible PRotein GADD34; Myeloid differentiation PRimary response PRotein MyD116 homolog; Ppp1r15a; PR15A_HUMAN; PRotein phosphatase 1 regulatory (inhibitor) subunit 15A; PRotein phosphatase 1 regulatory subunit 15A	Human	E. coli

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-N1423S

Glycocholic acid-d4

Glycocholic acid-d₄ is the deuterium labeled Glycocholic acid (HY-N1423). Glycocholic acid is a bile acid derivative. Glycocholic acid downregulates MDR1, Bcl-2, MRP1, MRP2 and FXR, upregulates Bax, p53, caspase-9, caspase-3, TGR5 and S1PR2. Glycocholic acid inhibits multidrug resistance and efflux pumps, induces mitochondrial apoptosis, and enhances chemosensitivity. Glycocholic acid modulates related bile acid receptor signaling. Glycocholic acid suppresses growth and conjugation of Enterobacteriaceae and increases their antibiotic susceptibility. Glycocholic acid can be used for the research of colon adenocarcinoma and cholangiocarcinoma (CCA).

HY-W011338S

Benzyl butyl phthalate-d4

Benzyl butyl phthalate-d₄ is the deuterium labeled Benzyl butyl phthalate . Benzyl butyl phthalate, a member of phthalic acid esters (PAEs), can trigger the migration and invasion of hemangioma (HA) cells via upregulation of Zeb1. Benzyl butyl phthalate activates aryl hydrocarbon receptor (AhR) in breast cancer cells to stimulate SPHK1/S1P/S1PR3 signaling and enhances formation of metastasis-initiating breast cancer stem cells (BCSCs) .

HY-10455S

Carfilzomib-d8
Carfilzomib-d₈ is deuterium labeled Carfilzomib. Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells.

HY-13683S

Mifepristone-d3
Mifepristone-d₃ is the deuterium labeled Mifepristone. Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC₅₀s of 0.2 nM and 2.6 nM in in vitro assay .

HY-13683S2

Mifepristone-d6
Mifepristone-d₆ is deuterated labeled Mifepristone (HY-13683). Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC₅₀s of 0.2 nM and 2.6 nM in in vitro assay .

HY-N1423S1

Glycocholic acid-d5

Glycocholic acid-d₅ is the deuterium labeled Glycocholic acid (HY-N1423). Glycocholic acid is a bile acid derivative. Glycocholic acid downregulates MDR1, Bcl-2, MRP1, MRP2 and FXR, upregulates Bax, p53, caspase-9, caspase-3, TGR5 and S1PR2. Glycocholic acid inhibits multidrug resistance and efflux pumps, induces mitochondrial apoptosis, and enhances chemosensitivity. Glycocholic acid modulates related bile acid receptor signaling. Glycocholic acid suppresses growth and conjugation of Enterobacteriaceae and increases their antibiotic susceptibility. Glycocholic acid can be used for the research of colon adenocarcinoma and cholangiocarcinoma (CCA).

HY-106827S1

Trimegestone-13C,d3

Trimegestone- ¹³C,d₃ is ¹³C and deuterated labeled Trimegestone (HY-106827). Trimegestone (RU 27987) is an orally active 19-norpregnane progestin. Trimegestone binds to progesterone receptor (PR) with an IC₅₀ value of 3.3 nM (rat PR). Trimegestone increases alkaline phosphatase activity (EC₅₀=0.1 nM) but not luciferase activity. Trimegestone also shows a weak antiandrogenic activity (weak androgen receptor affinity). Trimegestone can be used in studies of contraception or menopausal syndromes .

HY-14959S

Ulipristal-d3
Ulipristal-d₃ (CDB-3236-d₃) is deuterium labeled Ulipristal. Ulipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM). Ulipristal binds to the progesteron receptor, thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system .

HY-13683S1

Mifepristone-13C,d3

Mifepristone- ¹³C,d₃ is the ¹³C- and deuterium labeled Mifepristone. Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC₅₀s of 0.2 nM and 2.6 nM in in vitro assay . Mifepristone-13C,d3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-B0689S1

Indinavir-13C4,15N

Indinavir- ¹³C₄, ¹⁵N (MK-639 (free base)- ¹³C₄, ¹⁵N) is ¹³C and ¹⁵N labeled Indinavir. Indinavir (MK-639 free base) is an orally active and selective HIV-1 protease inhibitor with a K_i of 0.54 nM for PR. Indinavir exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir is also a SARS-CoV 3CL ^pro inhibitor .

HY-W754548

Glycocholic acid-13C2,d4

Glycocholic acid- ¹³C₂,d₄ is the deuterium labeled and ¹³C-labeled Glycocholic acid (HY-N1423). Glycocholic acid is a bile acid derivative. Glycocholic acid downregulates MDR1, Bcl-2, MRP1, MRP2 and FXR, upregulates Bax, p53, caspase-9, caspase-3, TGR5 and S1PR2. Glycocholic acid inhibits multidrug resistance and efflux pumps, induces mitochondrial apoptosis, and enhances chemosensitivity. Glycocholic acid modulates related bile acid receptor signaling. Glycocholic acid suppresses growth and conjugation of Enterobacteriaceae and increases their antibiotic susceptibility. Glycocholic acid can be used for the research of colon adenocarcinoma and cholangiocarcinoma (CCA).

Host:	Mouse (23) Rabbit (19)
Reactivity:	Human (41) Rat (12) Mouse (16) Monkey (2) Rabbit (1)
Application:	IHC-P (29) ICC/IF (15) IF-Tissue (2) IP (11) IHC-F (4) WB (29) ChIP (2) FC (17) ELISA (17)
Isotype:	IgG (18) IgG1 (14) IgG1,IgG/Kappa (1) IgG/Kappa (1) IgG2a (3) IgG2b (4)
Conjugation:	Non-conjugated (42) Biotin (1)
Clonality:	Polyclonal (1) Monoclonal (27) Monoclonal Antibody (1) Recombinant (13)
Modification:	Phosphorylated (1) Unmodified (28)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P83972

	Progesterone Receptor Antibody (YA3669) PR; NR3C3	WB, IHC-P, FC, ELISA	Human, Mouse
	Progesterone Receptor Antibody (YA3669) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Progesterone Receptor.

HY-P83972A

	Progesterone Receptor Antibody (YA3669)(PBS only) PR; NR3C3	WB, IHC-P, FC, ELISA	Human, Mouse
	Progesterone Receptor Antibody (YA3669) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Progesterone Receptor.

HY-P85965

	Progesterone Receptor Antibody (YA5657) PRogesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3;	IHC-P, WB, ICC/IF, ELISA	Human, Mouse, Rat, Rabbit
	Progesterone Receptor Antibody (YA5657) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Progesterone Receptor.

HY-P82121

	Progesterone Receptor Antibody (YA1866) PGR; NR3C3; PRogesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3	WB, IHC-P, ICC/IF, IP	Human
	Progesterone Receptor Antibody (YA1866) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Progesterone Receptor.

HY-P82991

	M6PR Antibody (YA2736) CD MPR; M6PR; Man6PR; MPR46; MPRD; SMPR	WB, ICC/IF, FC	Human, Mouse, Rat
	M6PR Antibody (YA2736) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to M6PR.

HY-P87351

	PRDM4 Antibody (YA7034) MGC45046 antibody; PFM 1 antibody; PFM1 antibody; PR domain containing 4 antibody; PR domain containing PRotein 4 antibody; PR domain zinc finger PRotein 4 antibody; PR domain zinc finger PRotein PFM 1 antibody; PR domain zinc finger PRotein PFM1 antibody; PR domain-containing PRotein 4 antibody; PR/SET domain 4 antibody	IHC-P, FC, ELISA	Human
	PRDM4 Antibody (YA7034) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PRDM4.

HY-P87351A

	PRDM4 Antibody (YA7034)(PBS only) MGC45046 antibody; PFM 1 antibody; PFM1 antibody; PR domain containing 4 antibody; PR domain containing PRotein 4 antibody; PR domain zinc finger PRotein 4 antibody; PR domain zinc finger PRotein PFM 1 antibody; PR domain zinc finger PRotein PFM1 antibody; PR domain-containing PRotein 4 antibody; PR/SET domain 4 antibody	WB, IHC-P, FC	Human
	PRDM4 Antibody (YA7034) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PRDM4.

HY-P84819

	KMT5A Antibody (YA4516) SET8; SET07; SETD8; PR-Set7; PR/SET07	IHC-P, FC, ELISA	Human
	KMT5A Antibody (YA4516) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to KMT5A.

HY-P84819A

	KMT5A Antibody (YA4516)(PBS only) SET8; SET07; SETD8; PR-Set7; PR/SET07	IHC-P, FC, ELISA	Human
	KMT5A Antibody (YA4516) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to KMT5A.

HY-P85332

	PR3 Antibody (YA5024) PRTN3; MBN; Myeloblastin; AGP7; C-ANCA antigen; Leukocyte PRoteinase 3; PR-3; PR3; Neutrophil PRoteinase 4; NP-4; P29; Wegener autoantigen	ICC/IF, FC, ELISA	Human, Mouse
	PR3 Antibody (YA5024) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to PR3.

HY-P82666

	Prolactin Receptor Antibody (YA2411) CPRLP; HPRL; hPRL receptor; Lactogen receptor; MFAB; OPR; PR-1; PR-3; PRLR; PRolactin receptor a	WB	Human, Mouse, Rat
	Prolactin Receptor Antibody (YA2411) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Prolactin Receptor.

HY-P84173

	M6PR Antibody (YA3870) SMPR; MPR46; CD-MPR; MPR 46; MPR-46; CD-M6PR	WB, IHC-P, FC, ELISA	Human, Mouse
	M6PR Antibody (YA3870) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to M6PR.

HY-P85332A

	PR3 Antibody (YA5024)(PBS only) PRTN3; MBN; Myeloblastin; AGP7; C-ANCA antigen; Leukocyte PRoteinase 3; PR-3; PR3; Neutrophil PRoteinase 4; NP-4; P29; Wegener autoantigen	ICC/IF, FC, ELISA	Human, Mouse
	PR3 Antibody (YA5024) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to PR3.

HY-P84173A

	M6PR Antibody (YA3870)(PBS only) SMPR; MPR46; CD-MPR; MPR 46; MPR-46; CD-M6PR	WB, IHC-P, FC, ELISA	Human, Mouse
	M6PR Antibody (YA3870) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to M6PR.

HY-P83011

	PR3 Antibody (YA2756) PRTN3; ACPA; CANCA	WB, IHC-P	Human
	PR3 Antibody (YA2756) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PR3.

HY-P80967

	S1PR4 Antibody EDG6; LPC1; S1P4; SLP4	WB, IHC-P	Rat
	S1PR4 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to S1PR4.

HY-P84818

	KMT5A Antibody (YA4515) SET8; SET07; SETD8; PR-Set7	ICC/IF, FC, ELISA	Human
	KMT5A Antibody (YA4515) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to KMT5A.

HY-P810350

	KMT5A Antibody (YA9672) PR-Set7, SET07, SET8, SETD8	IHC-P	Human
	KMT5A Antibody (YA9672) is a Mouse-derived and non-conjugated IgG1 Monoclonal antibody, targeting to KMT5A.

HY-P81991

	Phospho-Progesterone Receptor (Ser190) Antibody (YA1736) PGR; NR3C3; PRogesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3	WB, IHC-F, IHC-P, ICC/IF, IP	Human
	Phospho-Progesterone Receptor (Ser190) Antibody (YA1736) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-Progesterone Receptor (Ser190).

HY-P81631

	KMT5A Antibody (YA1376) KMT5A; PR-Set7; SET07; SET8	WB, FC	Human, Mouse, Rat
	KMT5A Antibody (YA1376) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to KMT5A.

HY-P86686

	PR3 Antibody (YA6378) ACPA; AGP 7; AGP7; AGP7 serine PRoteinase; Azurophil Granule PRotein 7; C ANCA antigen; C-ANCA antigen; EC 3.4.21.76; Leukocyte PRoteinase 3; MBN; MBT WEGENER AUTOANTIGEN; Myeloblastin; Neutrophil PRoteinase 4; NP 4; NP-4; NP4; P29; PR 3; PR-3; PRoteinase3; PRTN 3; PRtn3; PRTN3_HUMAN; Serine PRoteinase neutrophil Wegener granulomatosis autoantigen; Wegener autoantigen.	IHC-P, IHC-F, IF-Tissue	Human
	PR3 Antibody (YA6378) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PR3.

HY-P81991A

	Phospho-Progesterone Receptor (Ser190) Antibody (YA1736)(PBS only) PGR; NR3C3; PRogesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3	WB, IHC-F, IHC-P, ICC/IF, IP	Human
	Phospho-Progesterone Receptor (Ser190) Antibody (YA1736) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-Progesterone Receptor (Ser190).

HY-P84818A

	KMT5A Antibody (YA4515)(PBS only) SET8; SET07; SETD8; PR-Set7	ICC/IF, FC, ELISA	Human
	KMT5A Antibody (YA4515) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to KMT5A.

HY-P85937

	Stathmin 1 Antibody (YA5629) C1orf215; Lag; LAP 18; LAP18; Leukemia associated phosphoPRotein p18; Leukemia-associated phosphoPRotein p18; Metablastin; OncoPRotein 18; OP 18; Op18; p18; p19; PhosphoPRotein 19; PhosphoPRotein p19; pp17; pp19; PR22; PR22 PRotein; PRosolin; PRotein PR22; SMN; Stathmin; Stathmin1; STMN 1; Stmn1; STMN1_HUMAN	IHC-P, WB, ICC/IF, ELISA	Human, Mouse, Rat
	Stathmin 1 Antibody (YA5629) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to Stathmin 1.

HY-P81356

	PRDM1/Blimp1 Antibody (YA1101) PRDM1; BLIMP1; PR domain zinc finger PRotein 1; BLIMP-1; Beta-interferon gene positive regulatory domain I-binding factor; PR domain-containing PRotein 1; Positive regulatory domain I-binding factor 1 (PRDI-BF1; PRDI-binding factor 1)	IHC-P	Human
	PRDM1/Blimp1 Antibody (YA1101) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PRDM1/Blimp1.

HY-P85055

	PRDM1/Blimp1 Antibody (YA4747) PRDM1; BLIMP1; PR domain zinc finger PRotein 1; BLIMP-1; Beta-interferon gene positive regulatory domain I-binding factor; PR domain-containing PRotein 1; Positive regulatory domain I-binding factor 1; PRDI-BF1; PRDI-binding factor 1	WB, ELISA	Human, Mouse
	PRDM1/Blimp1 Antibody (YA4747) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to PRDM1/Blimp1.

HY-P81356A

	PRDM1/Blimp1 Antibody (YA1101)(PBS only) PRDM1; BLIMP1; PR domain zinc finger PRotein 1; BLIMP-1; Beta-interferon gene positive regulatory domain I-binding factor; PR domain-containing PRotein 1; Positive regulatory domain I-binding factor 1 (PRDI-BF1; PRDI-binding factor 1)	IHC-P	Human
	PRDM1/Blimp1 Antibody (YA1101) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PRDM1/Blimp1.

HY-P82160

	SC35 Antibody (YA1905) PRotein PR264; Splicing component; 35 kDa; Splicing factor SC35; SC-35; Splicing factor; arginine/serine-rich 2	WB, IHC-P, IP	Human, Rat
	SC35 Antibody (YA1905) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SC35.

HY-P81494

	S1P1/EDG1 Antibody (YA1239) S1PR1; EDG1; S1P1; ECGF1; EDG-1; CHEDG1; D1S3362	IHC-P	Human
	S1P1/EDG1 Antibody (YA1239) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to S1P1/EDG1.

HY-P84177

	S1P1/EDG1 Antibody (YA3874) S1PR1; EDG1; S1P1; ECGF1; EDG-1; CHEDG1; D1S3362	WB, IHC-P, FC, ELISA	Human
	S1P1/EDG1 Antibody (YA3874) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to S1P1/EDG1.

HY-P82160A

	SC35 Antibody (YA1905)(PBS only) PRotein PR264; Splicing component; 35 kDa; Splicing factor SC35; SC-35; Splicing factor; arginine/serine-rich 2	WB, IHC-P, IP	Human, Rat
	SC35 Antibody (YA1905) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SC35.

HY-P81494A

	S1P1/EDG1 Antibody (YA1239)(PBS only) S1PR1; EDG1; S1P1; ECGF1; EDG-1; CHEDG1; D1S3362	IHC-P	Human
	S1P1/EDG1 Antibody (YA1239) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to S1P1/EDG1.

HY-P84177A

	S1P1/EDG1 Antibody (YA3874)(PBS only) S1PR1; EDG1; S1P1; ECGF1; EDG-1; CHEDG1; D1S3362	WB, IHC-P, FC, ELISA	Human
	S1P1/EDG1 Antibody (YA3874) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to S1P1/EDG1.

HY-P82614

	EDG3 Antibody (YA2359) S1PR3; EDG3; Sphingosine 1-phosphate receptor 3; S1P receptor 3; S1P3; Endothelial differentiation G-PRotein coupled receptor 3; Sphingosine 1-phosphate receptor Edg-3; S1P receptor Edg-3	WB	Human, Mouse, Rat
	EDG3 Antibody (YA2359) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to EDG3.

HY-P80715

	HtrA2/Omi Antibody (YA726) High temperature requirement PRotein A2; HTRA 2; HtrA like serine PRotease; HtrA serine peptidase 2; HtrA; E. coli; homolog of; 2; HtrA2; HTRA2_HUMAN; mitochondrial; Omi stress regulated endoPRotease; Omi stress-regulated endoPRotease; PARK 13; PARK13; PR	WB, IP	Human
	HtrA2/Omi Antibody (YA726) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to HtrA2/Omi.

HY-P80715A

	HtrA2/Omi Antibody (YA726)(PBS only) High temperature requirement PRotein A2; HTRA 2; HtrA like serine PRotease; HtrA serine peptidase 2; HtrA; E. coli; homolog of; 2; HtrA2; HTRA2_HUMAN; mitochondrial; Omi stress regulated endoPRotease; Omi stress-regulated endoPRotease; PARK 13; PARK13; PR	WB, IP	Human
	HtrA2/Omi Antibody (YA726) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to HtrA2/Omi.

HY-P86479

	Ubiquitin K48 Antibody (YA6171) UBB; Polyubiquitin-B; UBC; Polyubiquitin-C; RPS27A; UBA80; UBCEP1; Ubiquitin-40S ribosomal PRotein S27a; Ubiquitin carboxyl extension PRotein 80; UBA52; UBCEP2; Ubiquitin-60S ribosomal PRotein L40; CEP52; Ubiquitin A-52 residue ribosomal PR; Ubiquitin K48;	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Ubiquitin K48 Antibody (YA6171) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Ubiquitin K48.

HY-P80737

	Ku80 Antibody (YA714) XRCC5; G22P2; X-ray repair cross-complementing PRotein 5; 86 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; CTC box-binding factor 85 kDa subunit; CTC85; CTCBF; DNA repair PR	WB, ICC/IF, IP, ChIP	Human, Monkey
	Ku80 Antibody (YA714) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Ku80.

HY-P85251

	Ku80 Antibody (YA4943) XRCC5; G22P2; X-ray repair cross-complementing PRotein 5; 86 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; CTC box-binding factor 85 kDa subunit; CTC85; CTCBF; DNA repair PR	WB, IHC-P, IHC-F, ICC/IF, IF-Tissue	Human
	Ku80 Antibody (YA4943) is a Rabbit-derived and non-conjugated monoclonal antibody, targeting to Ku80.

HY-P81754

	IGF2R Antibody (YA1499) IGF2R; MPRI; Cation-independent mannose-6-phosphate receptor; CI Man-6-P receptor; CI-MPR; M6PR; 300 kDa mannose 6-phosphate receptor; MPR 300; Insulin-like growth factor 2 receptor; Insulin-like growth factor II receptor; IGF-II receptor; M6P/IGF2 receptor; M6P/IGF2R; CD222	WB, IHC-P, ICC/IF, IP, FC	Human, Mouse, Rat
	IGF2R Antibody (YA1499) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to IGF2R.

HY-P80737A

	Ku80 Antibody (YA714)(PBS only) XRCC5; G22P2; X-ray repair cross-complementing PRotein 5; 86 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; CTC box-binding factor 85 kDa subunit; CTC85; CTCBF; DNA repair PR	WB, ICC/IF, IP, ChIP	Human, Monkey
	Ku80 Antibody (YA714) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Ku80.

HY-P86935

	KRAS Antibody (YA6628) c Ki ras2 antibody; c Kirsten ras PRotein antibody; c-K-ras antibody; c-Ki-ras antibody; Cellular c Ki ras2 PRoto oncogene antibody; Cellular transforming PRoto oncogene antibody; CFC2 antibody; cK Ras antibody; GTPase KRas antibody; K RAS p21 PRotein antibody; c Ki ras2 antibody; c Kirsten ras PRotein antibody; c-K-ras antibody; c-Ki-ras antibody; Cellular c Ki ras2 PRoto oncogene antibody; Cellular transforming PRoto oncogene antibody; CFC2 antibody; cK Ras antibody; GTPase KRas antibody; K RAS p21 PRotein antibody; K RAS2A antibody; K RAS2B antibody; K RAS4A antibody; K RAS4B antibody; K-Ras 2 antibody; KI RAS antibody; Ki-Ras antibody; KIRSTEN MURINE SARCOMA VIRUS 2 antibody; Kirsten rat sarcoma 2 viral (v Ki ras2) oncogene homolog antibody; Kirsten rat sarcoma viral oncogene homolog antibody; KRAS antibody; KRAS PRoto oncogene, GTPase antibody; KRAS1 antibody; KRAS2 antibody; N-terminally PRocessed antibody; NS antibody; NS3 antibody; Oncogene KRAS2 antibody; p21ras antibody; PR310 c K ras oncogene antibody; PR310 cK ras oncogene antibody; RALD antibody; RASK_HUMAN antibody; RASK2 antibody; Transforming PRotein p21 antibody; v Ki ras2 Kirsten rat sarcoma 2 viral oncogene homolog antibody; v Ki ras2 Kirsten rat sarcoma viral oncogene homolog antibody;	WB, IHC-P	Human, Mouse, Rat
	KRAS Antibody (YA6628) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to KRAS.